Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2023

Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Research Report 2023

Table of Contents
1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Overview
1.1 Product Overview and Scope of Glucagon Like Peptide-1 (GLP-1) Agonists
1.2 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Type
1.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Value Comparison by Type (2023-2029)
1.2.2 Exenatied
1.2.3 Liraglutide
1.2.4 Lixisenatide
1.2.5 Albiglutide
1.2.6 Dulaglutide
1.3 Glucagon Like Peptide-1 (GLP-1) Agonists Segment by Application
1.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size Estimates and Forecasts
1.4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue 2018-2029
1.4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales 2018-2029
1.4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competition by Manufacturers
2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Manufacturers (2018-2023)
2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price by Manufacturers (2018-2023)
2.4 Global Glucagon Like Peptide-1 (GLP-1) Agonists Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists, Product Type & Application
2.7 Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation and Trends
2.7.1 Glucagon Like Peptide-1 (GLP-1) Agonists Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Glucagon Like Peptide-1 (GLP-1) Agonists Players Market Share by Revenue
2.7.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Glucagon Like Peptide-1 (GLP-1) Agonists Retrospective Market Scenario by Region
3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region: 2018-2029
3.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region: 2018-2023
3.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region: 2024-2029
3.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region: 2018-2029
3.3.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region: 2018-2023
3.3.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region: 2024-2029
3.4 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures by Country
3.4.1 North America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2029)
3.4.3 North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures by Country
3.5.1 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2029)
3.5.3 Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures by Country
3.6.1 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2029)
3.6.3 Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures by Country
3.7.1 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2029)
3.7.3 Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Facts & Figures by Country
3.8.1 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2029)
3.8.3 Middle East and Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2029)
4.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2018-2023)
4.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Type (2024-2029)
4.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2018-2029)
4.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2018-2029)
4.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2018-2023)
4.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Type (2024-2029)
4.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2018-2029)
4.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Type (2018-2029)
5 Segment by Application
5.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2029)
5.1.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2018-2023)
5.1.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Application (2024-2029)
5.1.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2018-2029)
5.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2018-2029)
5.2.1 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2018-2023)
5.2.2 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Application (2024-2029)
5.2.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2018-2029)
5.3 Global Glucagon Like Peptide-1 (GLP-1) Agonists Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Corporation Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Eli Lily
6.3.1 Eli Lily Corporation Information
6.3.2 Eli Lily Description and Business Overview
6.3.3 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.3.5 Eli Lily Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Corporation Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Corporation Information
6.6.2 Bristol-Myers Squibb Description and Business Overview
6.6.3 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.6.5 Bristol-Myers Squibb Recent Developments/Updates
6.7 Amylin
6.6.1 Amylin Corporation Information
6.6.2 Amylin Description and Business Overview
6.6.3 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product Portfolio
6.7.5 Amylin Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Chain Analysis
7.2 Glucagon Like Peptide-1 (GLP-1) Agonists Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glucagon Like Peptide-1 (GLP-1) Agonists Production Mode & Process
7.4 Glucagon Like Peptide-1 (GLP-1) Agonists Sales and Marketing
7.4.1 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Channels
7.4.2 Glucagon Like Peptide-1 (GLP-1) Agonists Distributors
7.5 Glucagon Like Peptide-1 (GLP-1) Agonists Customers
8 Glucagon Like Peptide-1 (GLP-1) Agonists Market Dynamics
8.1 Glucagon Like Peptide-1 (GLP-1) Agonists Industry Trends
8.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
8.3 Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
8.4 Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Competitive Situation by Manufacturers in 2022
Table 4. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Glucagon Like Peptide-1 (GLP-1) Agonists Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Glucagon Like Peptide-1 (GLP-1) Agonists, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists, Product Type & Application
Table 12. Global Key Manufacturers of Glucagon Like Peptide-1 (GLP-1) Agonists, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon Like Peptide-1 (GLP-1) Agonists as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2018-2023) & (K Units)
Table 18. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2018-2023)
Table 19. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2024-2029) & (K Units)
Table 20. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2024-2029)
Table 21. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2018-2023)
Table 23. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2024-2029)
Table 25. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2023) & (K Units)
Table 27. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2029) & (K Units)
Table 28. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2023) & (K Units)
Table 32. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2029) & (K Units)
Table 33. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2018-2023)
Table 51. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Type (2024-2029)
Table 52. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2018-2023)
Table 53. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Type (2024-2029)
Table 54. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2018-2023)
Table 57. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Type (2024-2029)
Table 58. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Type (2018-2023)
Table 59. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Type (2024-2029)
Table 60. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2018-2023)
Table 61. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units) by Application (2024-2029)
Table 62. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2018-2023)
Table 63. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Application (2024-2029)
Table 64. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2018-2023)
Table 67. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Application (2024-2029)
Table 68. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Application (2018-2023)
Table 69. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Application (2024-2029)
Table 70. Novo Nordisk Corporation Information
Table 71. Novo Nordisk Description and Business Overview
Table 72. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Novo Nordisk Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 74. Novo Nordisk Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. AstraZeneca Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Eli Lily Corporation Information
Table 81. Eli Lily Description and Business Overview
Table 82. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Eli Lily Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 84. Eli Lily Recent Developments/Updates
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. GSK Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 89. GSK Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Sanofi Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Bristol-Myers Squibb Corporation Information
Table 96. Bristol-Myers Squibb Description and Business Overview
Table 97. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Bristol-Myers Squibb Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 99. Bristol-Myers Squibb Recent Developments/Updates
Table 100. Amylin Corporation Information
Table 101. Amylin Description and Business Overview
Table 102. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Amylin Glucagon Like Peptide-1 (GLP-1) Agonists Product
Table 104. Amylin Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Glucagon Like Peptide-1 (GLP-1) Agonists Distributors List
Table 108. Glucagon Like Peptide-1 (GLP-1) Agonists Customers List
Table 109. Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
Table 110. Glucagon Like Peptide-1 (GLP-1) Agonists Market Drivers
Table 111. Glucagon Like Peptide-1 (GLP-1) Agonists Market Challenges
Table 112. Glucagon Like Peptide-1 (GLP-1) Agonists Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Glucagon Like Peptide-1 (GLP-1) Agonists
Figure 2. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Type in 2022 & 2029
Figure 4. Exenatied Product Picture
Figure 5. Liraglutide Product Picture
Figure 6. Lixisenatide Product Picture
Figure 7. Albiglutide Product Picture
Figure 8. Dulaglutide Product Picture
Figure 9. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Pharmacy
Figure 13. Other
Figure 14. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size (2018-2029) & (US$ Million)
Figure 16. Global Glucagon Like Peptide-1 (GLP-1) Agonists Sales (2018-2029) & (K Units)
Figure 17. Global Glucagon Like Peptide-1 (GLP-1) Agonists Average Price (USD/Unit) & (2018-2029)
Figure 18. Glucagon Like Peptide-1 (GLP-1) Agonists Report Years Considered
Figure 19. Glucagon Like Peptide-1 (GLP-1) Agonists Sales Share by Manufacturers in 2022
Figure 20. Global Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Glucagon Like Peptide-1 (GLP-1) Agonists Players: Market Share by Revenue in 2022
Figure 22. Glucagon Like Peptide-1 (GLP-1) Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2018-2029)
Figure 25. North America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2018-2029)
Figure 26. U.S. Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2018-2029)
Figure 29. Europe Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2018-2029)
Figure 30. Germany Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Region (2018-2029)
Figure 37. China Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Indonesia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Thailand Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Malaysia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Philippines Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2018-2029)
Figure 48. Latin America Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2018-2029)
Figure 49. Mexico Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Sales Market Share by Country (2018-2029)
Figure 53. Middle East & Africa Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Market Share by Country (2018-2029)
Figure 54. Turkey Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. U.A.E Glucagon Like Peptide-1 (GLP-1) Agonists Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Global Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2018-2029)
Figure 58. Global Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Type (2018-2029)
Figure 59. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Type (2018-2029)
Figure 60. Global Sales Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application (2018-2029)
Figure 61. Global Revenue Market Share of Glucagon Like Peptide-1 (GLP-1) Agonists by Application (2018-2029)
Figure 62. Global Glucagon Like Peptide-1 (GLP-1) Agonists Price (USD/Unit) by Application (2018-2029)
Figure 63. Glucagon Like Peptide-1 (GLP-1) Agonists Value Chain
Figure 64. Glucagon Like Peptide-1 (GLP-1) Agonists Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Repaglinide Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 124

The Repaglinide market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Repaglinide industry, and breaks down according to the type, application, and consumption area of Repaglinide. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......

Global Human Insulin Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 21-Mar-2023        Price: US 3260 Onwards        Pages: 128

The Human Insulin market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Human Insulin industry, and breaks down according to the type, application, and consumption area of Human Insulin. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading comp......

Global Gliclazide Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 14-Mar-2023        Price: US 3260 Onwards        Pages: 102

The Gliclazide market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Gliclazide industry, and breaks down according to the type, application, and consumption area of Gliclazide. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......

2023-2031 Report on Global Liraglutide Market by Player, Region, Type, Application and Sales Channel

Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 91

This report studies the Liraglutide market, covering market size for segment by type (Pills, Liquid, etc.), by application (Hospitals, Retail Pharmacy, etc.), by sales channel (Direct Channel, Distribution Channel), by player (HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market......

2023-2031 Report on Global Insulin Glargine Market by Player, Region, Type, Application and Sales Channel

Published: 13-Mar-2023        Price: US 2500 Onwards        Pages: 86

This report studies the Insulin Glargine market, covering market size for segment by type (Single Dose Vial, Pre-filled Syringe, etc.), by application (Treat Type 2 Diabetes, Treat Type 1 Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Sanofi-Aventis, Ganlee, Biocon, ..., , etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Ins......

Global Glipizide Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Glipizide (CAS 29094-61-9), C21H27N5O4S, the formula weight is 445.54, and its form is white cyrstal powder. Highlights The global Glipizide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Glipizide is a hypoglycemic drug for non-insulin-dependent (II) type diabe......

Global Gliquidone Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 91

Gliquidone (CAS 33342-05-1), C27H33N3O6S, the formula weight is 527.63, and its form is white powder. Highlights The global Gliquidone market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Glycollinone is a second-generation oral sulfonylurea hypoglycemic agent. It is ......

Global Diabetes Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 02-Mar-2023        Price: US 3260 Onwards        Pages: 98

The Diabetes Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Diabetes Drugs industry, and breaks down according to the type, application, and consumption area of Diabetes Drugs. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading c......

Global Glimepiride Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 28-Feb-2023        Price: US 3260 Onwards        Pages: 115

The Glimepiride market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Glimepiride industry, and breaks down according to the type, application, and consumption area of Glimepiride. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs